INCYTE Corporation (INCY)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO:
Hervé Hoppenot
Employees:
700
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE 19803
3024986700

Incyte Corp. is a biopharmaceutical company, which focuses on the discovery, development, development, formulation, manufacturing and commercialization of proprietary therapeutics to treat serious unmet medical needs, primarily in oncology. Its product, Jakafi, a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers. The companywas founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Data derived from most recent annual or quarterly report
Market Cap 14.529 Billion Shares Outstanding220.835 Million Avg 30-day Volume 1.586 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 101.47 / 64.08 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from INCY instead.

View recent insider trading info

Funds Holding INCY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding INCY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

777 total shares from 2 transactions

Exercise Derivative Conversion (M)

1.7 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DHANAK DASHYANT EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
31,263 2021-10-01 15

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
32,525,187 2021-09-30 5

HARRIGAN EDMUND

  • Director
5,079 2021-09-30 5

DIXON WENDY L

  • Director
17,259 2021-09-30 5

FOUSE JACQUALYN A

  • Director
7,942 2021-09-30 5

CLANCY PAUL J

  • Director
7,621 2021-09-30 5

BRAWLEY OTIS W

  • Director
0 2021-09-27 2

PASQUALE MARIA E EVP & GENERAL COUNSEL

  • Officer
38,099 2021-09-24 12

SWAIN PAULA J EVP, HUMAN RESOURCES

  • Officer
60,959 2021-09-20 4

IYENGAR VIJAY K EVP GPS, BD, & LICENSING

  • Officer
27,005 2021-07-29 5

STAMOULIS CHRISTIANA EVP & CHIEF FINANCIAL OFFICER

  • Officer
55,319 2021-07-02 4

HOPPENOT HERVE CHAIRMAN / CEO

  • Officer
  • Director
  • PRESIDENT
793,368 2021-07-02 4

FLANNELLY BARRY P EVP & GENERAL MANAGER US

  • Officer
127,087 2021-07-02 5

WENQING YAO EVP, HEAD OF DISCOVERY CHEM

  • Officer
212,609 2021-07-02 5

TROWER PAUL PRINCIPAL ACCOUNTING OFFICER

  • Officer
67,890 2021-07-02 2

STEIN STEVEN H EVP & CHIEF MEDICAL OFFICER

  • Officer
219,782 2021-07-02 5

BIENAIME JEAN JACQUES

  • Director
18,854 2021-05-26 3

HIGH KATHERINE A

  • Director
11,354 2021-05-26 1

MORRISSEY MICHAEL JAMES EVP, HEAD OF TECH. OPERATIONS

  • Officer
45,452 2021-03-29 4

DICKINSON JONATHAN ELLIOTT EVP, GENERAL MANAGER, EUROPE

  • Officer
27,135 2021-01-25 3

FRIEDMAN PAUL A

  • Director
271,813 2020-05-26 0

BROOKE PAUL A

  • Director
261,911 2020-03-31 0

BAKER BROS. ADVISORS LP

14159, L.P.

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
32,431,899 2019-06-06 5

GRYSKA DAVID W EXECUTIVE VICE PRESIDENT, CFO

  • Officer
10,235 2018-07-16 0

HUBER REID M EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
34,571 2018-07-16 0

SIEGEL ERIC H. EVP, GENERAL COUNSEL

  • Officer
21,053 2017-09-13 0

LEVY RICHARD S EVP, CHIEF DRUG DEV OFFICER

  • Officer
16,926 2016-01-06 0

DALY JAMES M EVP, CHIEF COMMERCIAL OFFICER

  • Officer
3,521 2015-06-23 0

CHARDONNET LAURENT

  • VICE PRESIDENT AND TREASURER
2,905 2015-03-30 0

ARIKO BARRY A

  • Director
45,834 2015-03-12 0

DE SCHUTTER RICHARD U

  • Director
  • CHAIRMAN
92,290 2015-03-05 0

HASTINGS DAVID C CHIEF FINANCIAL OFFICER

  • Officer
8,500 2014-06-04 0

WHITFIELD ROY A

  • Director
666,082 2013-12-17 0

BAKER BROS. ADVISORS (GP) LLC

  • Director
  • 10% Owner
0 2013-07-01 0

BAKER JULIAN

BAKER FELIX

BAKER BROS ADVISORS LLC

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

  • Director
  • 10% Owner
15,023,952 2013-06-11 0

BAKER BROTHERS LIFE SCIENCES LP

  • Director
12,445,783 2013-06-11 0

14159, L.P.

  • Director
370,839 2013-06-11 0

667, L.P.

  • Director
2,038,937 2013-06-11 0

BAKER JULIAN

  • Director
  • 10% Owner
0 2013-05-30 0

FBB ASSOCIATES

  • Director
  • 10% Owner
33,410 2012-06-15 0

FBB2 LLC

  • Director
  • 10% Owner
15,110 2012-06-15 0

BAKER BROS ADVISORS LLC

  • Director
  • 10% Owner
0 2012-04-12 0

ANDREWS PATRICIA S CHIEF COMMERCIAL OFFICER

  • Officer
0 2012-01-19 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
12,430,783 2012-01-12 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
355,839 2012-01-12 0

BAKER BROS. CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
227,594 2011-06-30 0

NIBLACK JOHN F

  • Director
0 2011-05-20 0

SCHRECK PATRICIA A EVP, GENERAL COUNSEL

  • Officer
4,500 2011-05-09 0

METCALF BRIAN W CHIEF DRUG DISCOVERY SCIENTIST

  • Officer
66,504 2011-04-11 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
2,933,021 2010-09-21 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
159,739 2010-09-21 0

FRIEDMAN STEVEN M. EVP, BIOLOGY & PRECLINICAL DEV

  • Officer
0 2010-05-18 0

EMMENS MATTHEW

  • Director
0 2008-05-22 0

KELLER JOHN A CHIEF BUSINESS OFFICER

  • Officer
0 2008-02-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DHANAK DASHYANT - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-10-04 16:41:25 -0400 2021-10-01 S 389 $68.67 d 31,263 direct 0.75 -1.4848 0.8572 4 -1.4848 6

FOUSE JACQUALYN A - Director

2021-10-04 16:32:44 -0400 2021-09-30 A 271 $68.78 a 7,942 direct 0.75 -1.4848 0.8572 4 -1.4848 6

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2021-10-04 16:01:54 -0400 2021-09-30 A 393 a 29,337,177 indirect 0.75 -1.4848 0.8572 4 -1.4848 6

CLANCY PAUL J - Director

2021-10-04 16:26:03 -0400 2021-09-30 A 321 $68.78 a 7,621 direct 0.75 -1.4848 0.8572 4 -1.4848 6

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2021-10-04 16:01:54 -0400 2021-09-30 A 393 a 2,873,410 indirect 0.75 -1.4848 0.8572 4 -1.4848 6

HARRIGAN EDMUND - Director

2021-10-04 16:36:09 -0400 2021-09-30 A 237 $68.78 a 5,079 direct 0.75 -1.4848 0.8572 4 -1.4848 6

DIXON WENDY L - Director

2021-10-04 16:28:51 -0400 2021-09-30 A 244 $68.78 a 17,259 direct 0.75 -1.4848 0.8572 4 -1.4848 6

BRAWLEY OTIS W - Director

2021-09-29 18:19:29 -0400 2021-09-27 A 1,255 a 1,255 direct -0.8287 -4.5507 0.0 1 -5.016 4

BRAWLEY OTIS W - Director

2021-09-29 18:19:29 -0400 2021-09-27 A 5,910 a 5,910 direct

PASQUALE MARIA E - Officer EVP & GENERAL COUNSEL

2021-09-28 08:18:12 -0400 2021-09-24 M 382 d 1,912 direct

PASQUALE MARIA E - Officer EVP & GENERAL COUNSEL

2021-09-28 08:18:12 -0400 2021-09-24 M 382 $65.36 a 36,187 direct -0.0146 -4.8777 0.1456 3 -4.8777 6

SWAIN PAULA J - Officer EVP, HUMAN RESOURCES

2021-09-21 16:09:48 -0400 2021-09-20 M 1,356 d 0 direct

SWAIN PAULA J - Officer EVP, HUMAN RESOURCES

2021-09-21 16:09:48 -0400 2021-09-20 M 1,356 $73.21 a 60,959 direct 0.273 -1.322 0.273 2 -1.322 6

DHANAK DASHYANT - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-09-03 07:40:32 -0400 2021-09-01 S 388 $76.71 d 31,652 direct -1.8268 -4.7838 -15.1268 0.0 1 -15.5999 28

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INCYTE CORP INCY 2021-10-26 18:45:03 UTC -0.2589 0.3289 5100000
INCYTE CORP INCY 2021-10-26 18:15:03 UTC -0.2589 0.3289 5100000
INCYTE CORP INCY 2021-10-26 17:45:03 UTC -0.2589 0.3289 5100000
INCYTE CORP INCY 2021-10-26 17:15:03 UTC -0.2589 0.3289 5100000
INCYTE CORP INCY 2021-10-26 16:45:04 UTC -0.18 0.25 5100000
INCYTE CORP INCY 2021-10-26 16:15:03 UTC -0.18 0.25 5100000
INCYTE CORP INCY 2021-10-26 15:45:03 UTC -0.18 0.25 5100000
INCYTE CORP INCY 2021-10-26 15:15:03 UTC -0.18 0.25 5100000
INCYTE CORP INCY 2021-10-26 14:45:03 UTC -0.18 0.25 5100000
INCYTE CORP INCY 2021-10-26 14:15:05 UTC -0.18 0.25 5000000
INCYTE CORP INCY 2021-10-26 13:45:03 UTC -0.18 0.25 5000000
INCYTE CORP INCY 2021-10-26 13:15:03 UTC -0.18 0.25 5000000
INCYTE CORP INCY 2021-10-26 12:45:03 UTC -0.18 0.25 4900000
INCYTE CORP INCY 2021-10-25 22:15:03 UTC -0.18 0.25 3500000
INCYTE CORP INCY 2021-10-25 21:45:03 UTC -0.18 0.25 3500000
INCYTE CORP INCY 2021-10-25 21:15:03 UTC -0.18 0.25 3500000
INCYTE CORP INCY 2021-10-25 20:45:03 UTC -0.18 0.25 3500000
INCYTE CORP INCY 2021-10-25 20:15:03 UTC -0.18 0.25 3500000
INCYTE CORP INCY 2021-10-25 19:45:04 UTC -0.18 0.25 3500000
INCYTE CORP INCY 2021-10-25 19:15:03 UTC -0.18 0.25 3500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund INCY -292.0 shares, $-25398.16 2020-12-31 N-PORT
FundVantage Trust- Gotham Absolute 500 Core Fund INCY -59.0 shares, $-4320.57 2020-03-31 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund INCY -1059.0 shares, $-92111.82 2020-12-31 N-PORT
Nuveen Investment Trust- Nuveen Equity Market Neutral Fund INCY -2100.0 shares, $-175938.0 2021-05-31 N-PORT
Nuveen Investment Trust II- Nuveen Equity Long/Short Fund INCY -5800.0 shares, $-485924.0 2021-05-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF INCY -2863.0 shares, $-240864.19 2021-06-30 N-PORT
INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund INCY -864.0 shares, $-72688.32 2021-06-30 N-PORT
ADVISORS' INNER CIRCLE FUND II- Hancock Horizon Quantitative Long/Short Fund INCY -3670.0 shares, $-308757.1 2021-06-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund INCY -114.0 shares, $-9590.82 2021-06-30 N-PORT

Elevate your investments